[SARM1](/proteins/sarm1-protein) (Sterile Alpha and TIR Motif Containing 1) plays an important role in [neurodegenerative diseases](/diseases/alzheimers-disease). This page provides comprehensive information about its mechanisms, significance in disease processes, and therapeutic implications.
Introduction
[SARM1](/proteins/sarm1-protein) is an important component in the neurobiology of [Alzheimer's disease](/diseases/alzheimers-disease), [Parkinson's disease](/diseases/parkinsons-disease), [ALS](/diseases/amyotrophic-lateral-sclerosis), and other neurodegenerative conditions. This page provides detailed information about its structure, function, and role in disease processes.
SARM1 is the central executioner of [programmed axon degeneration](/mechanisms/wallerian-degeneration). Its intrinsic [NADase](/mechanisms/nad-metabolism) activity triggers rapid axonal breakdown following injury, making it a critical therapeutic target for [Wallerian degeneration](/mechanisms/wallerian-degeneration), [ALS](/diseases/amyotrophic-lateral-sclerosis), [PD](/diseases/parkinsons-disease), and [AD](/diseases/alzheimers-disease).
In [neurodegenerative diseases](/diseases/alzheimers-disease), SARM1 activation contributes to:
[Axonal degeneration](/mechanisms/wallerian-degeneration) in distal axons
[Synaptic loss](/mechanisms/synaptic-dysfunction-pathway) preceding neuron death
[Mitochondrial dysfunction](/mechanisms/mitochondrial-dysfunction) in neurodegeneration
[NAD+ depletion](/mechanisms/nad-metabolism) leading to metabolic collapse
Protein Overview
Structure
Domain Architecture:
N-terminal SAM Domain: Protein oligomerization and interactions
TIR Domain: Catalytic domain with NADase activity
Linker Region: Connects SAM and TIR domains
Structural Features:
Forms functional dimers and higher-order oligomers
TIR domain catalyzes NAD+ cleavage
Activation leads to conformational changes
Normal Function
NADase Activity:
Substrate: NAD+ → ADP-ribose + nicotinamide
Products: Generates cyclic ADP-ribose (cADPR) and nicotinamide
Rate: Extremely rapid upon activation
Axon Degeneration Pathway:
Axon injury → NMNAT2 degradation
Loss of NMNAT2 function → SARM1 activation
SARM1 NADase rapidly depletes axonal NAD+
Energy crisis → Axonal breakdown
Innate Immune Function:
Functions as pattern recognition receptor
Responds to pathogen-associated molecular patterns
Can be activated by sterile triggers
Role in Disease
Wallerian Degeneration:
SARM1 is the central executioner
Blocking SARM1 preserves axons for weeks after injury
SARM1 knockout mice are resistant to chemotherapy neuropathy
Major clinical challenge for cancer treatment
Traumatic Brain Injury:
Secondary axonal injury mediated by SARM1
SARM1 inhibition may improve outcomes
Peripheral Neuropathy:
Diabetic neuropathy involves SARM1 activation
Potential therapeutic target
Therapeutic Targeting
SARM1 Inhibitors:
Clinical Applications:
Chemotherapy-induced neuropathy prevention
Traumatic nerve injury treatment
Peripheral neuropathy management
Overview
Sarm1 Protein plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
Background
The study of Sarm1 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
See Also
[Related Topics](/index)
External Links
References
[Essuman K, et al, (2017) (2017)](https://pubmed.ncbi.nlm.nih.gov/28279355/)
[Gilley J, et al, (2015) (2015)](https://pubmed.ncbi.nlm.nih.gov/26189314/)
[Sasaki Y, et al, (2016) (2016)](https://pubmed.ncbi.nlm.nih.gov/27984726/)
[Geisler S, et al, (2019) (2019)](https://pubmed.ncbi.nlm.nih.gov/27591035/)
[Liu HW, et al, (2020) (2020)](https://pubmed.ncbi.nlm.nih.gov/32060476/)